by Brooke Blazr | Aug 22, 2026 | High Dispatch
On July 31, 2026, the Texas Department of State Health Services reinstated controlled-substance definitions it first adopted back in 2021, classifying delta-8, delta-10, THCP, and most other non-delta-9 THC compounds as Schedule I controlled substances under state...
by Brooke Blazr | Aug 18, 2026 | High Dispatch
Here’s a fact that gets lost in the cigarette-versus-weed conversation: nicotine is a genuinely psychoactive stimulant. It binds nicotinic acetylcholine receptors and triggers a dopamine release, and in a naive or recently-abstinent user, it produces a real...
by Brooke Blazr | Aug 14, 2026 | High Dispatch
Strip away the political baggage and “synthetic” is a chemistry term. It describes a compound assembled through a manufactured chemical process rather than pulled directly out of a living organism. That’s it. Aspirin is synthetic. Insulin used by...
by Brooke Blazr | Aug 11, 2026 | High Dispatch
SAMHSA dropped its annual National Survey on Drug Use and Health at the end of July, and the numbers should be front page news in every state legislature still clutching pearls over legalization. Past-month cannabis use among teenagers fell 22 percent between 2022...
by Brooke Blazr | Aug 8, 2026 | High Dispatch
WASHINGTON — The U.S. Senate has passed a government funding bill that would give the nation’s embattled hemp industry roughly one more month before sweeping federal restrictions on hemp-derived THC products take effect. The Senate approved the stopgap spending...